placebo in control group

2 trials

Sponsors

Tehran university of medical sciences, Mashhad University Of Medical Siences

Conditions

Condition 1: CKD. Condition 2: CKD stage 2-4. Chronic kidney disease Kidney damage with mild decreased GFR (60-89 mL/minsecondary pulmonary hypertension. Chronic lower respiratory diseases

Phase 3

The effect of atorvastatin on the treatment of secondary pulmonary hypertension

Active, not recruitingIRCT201108257411N1

Tehran university of medical sciencessecondary pulmonary hypertension. Chronic lower respiratory diseases

Start: 2009-03-20Target: 60Updated: 2018-02-22

Unknown Phase

Assessing Allopurinol Effect on Metabolic Acidosis in Patients with Chronic renal failure stage 2-4

Active, not recruitingIRCT2016122731604N1

Mashhad University Of Medical SiencesCondition 1: CKD. Condition 2: CKD stage 2-4. Chronic kidney disease Kidney damage with mild decreased GFR (60-89 mL/min

Start: 2017-04-30Target: 50Updated: 2018-02-22

Related Papers

Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial.

2013-08-0525 citations